Forward Therapeutics
PrivateLast Round
Series A
Oct 31, 2023
Total Funding Raised
$66M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Forward Therapeutics is a biotechnology company that develops oral small-molecule therapies for the treatment of inflammation-driven diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Forward Therapeutics Comparables
Compare Forward Therapeutics with similar companies based on industry and business-model similarity.
Forward Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 31, 2023 | ||||
| Seed | May 1, 2022 |
Forward Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series A |
| OrbiMed | Series A |
| BVF Partners L.P. | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 300% MoM, reaching 1.8K.
- Apr 18, 2026
Monthly visitors increased 42% MoM, from 757 to 1.1K.
Forward Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Forward Therapeutics's valuation, stock price, and market status.
Is Forward Therapeutics a public or private company?
Forward Therapeutics is a private company.
What is the current stock price of Forward Therapeutics?
Forward Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Forward Therapeutics worth (valuation)?
Valuation information for Forward Therapeutics is not publicly available.
Can I buy Forward Therapeutics stock?
Forward Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Forward Therapeutics's last funding round?
Forward Therapeutics's most recent funding round was Series A on November 8, 2023.
Who are the main investors in Forward Therapeutics?
Key investors in Forward Therapeutics include RA Capital Management, OrbiMed.
Will Forward Therapeutics IPO soon?
No public IPO plans have been announced for Forward Therapeutics.
How can I track Forward Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Forward Therapeutics's secondary market activity and sign up for updates.